# Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation

> **NCT01243008** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 32 (actual)

## Conditions studied

- Lyme Disease

## Interventions

- **DRUG:** Application of SHB001

## Key facts

- **NCT ID:** NCT01243008
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-11-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243008, "Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01243008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*